{"doc_id": "PMC-2065877-07-Results-06.txt", "sent_id": "S1", "tokens": ["LMP1", "Activates", "Akt", "Signaling", "and", "Deregulates", "the", "Rb", "Cell", "Cycle", "Pathway"], "sentence": "LMP1 Activates Akt Signaling and Deregulates the Rb Cell Cycle Pathway", "event_mentions": [], "entity_mentions": [{"id": "T1", "text": "LMP1", "entity_type": "Protein", "start": 0, "end": 0}, {"id": "T2", "text": "Akt", "entity_type": "Protein", "start": 2, "end": 2}, {"id": "T3", "text": "Rb", "entity_type": "Protein", "start": 7, "end": 7}]}
{"doc_id": "PMC-2065877-07-Results-06.txt", "sent_id": "S2", "tokens": ["LMP1", "transformation", "of", "rodent", "fibroblasts", "requires", "activation", "of", "PI3K", "and", "Akt", "[", "5", "]", "."], "sentence": "LMP1 transformation of rodent fibroblasts requires activation of PI3K and Akt [ 5 ] .", "event_mentions": [{"id": "E1", "event_type": "Positive_regulation", "trigger": {"text": "requires", "start": 5, "end": 5}, "arguments": [{"entity_id": "T70", "text": "activation", "role": "Theme"}]}, {"id": "E2", "event_type": "Positive_regulation", "trigger": {"text": "activation", "start": 6, "end": 6}, "arguments": [{"entity_id": "T5", "text": "Akt", "role": "Theme"}]}], "entity_mentions": [{"id": "T4", "text": "LMP1", "entity_type": "Protein", "start": 0, "end": 0}, {"id": "T5", "text": "Akt", "entity_type": "Protein", "start": 10, "end": 10}, {"id": "T69", "text": "requires", "entity_type": "Positive_regulation", "start": 5, "end": 5}, {"id": "T70", "text": "activation", "entity_type": "Positive_regulation", "start": 6, "end": 6}]}
{"doc_id": "PMC-2065877-07-Results-06.txt", "sent_id": "S3", "tokens": ["Additionally", ",", "activated", "pAkt", "is", "frequently", "detected", "in", "NPC", "and", "the", "neoplastic", "Reed-Sternberg", "cells", "of", "classical", "HD", "[", "39", ",", "40", "]", "."], "sentence": "Additionally , activated pAkt is frequently detected in NPC and the neoplastic Reed-Sternberg cells of classical HD [ 39 , 40 ] .", "event_mentions": [{"id": "E3", "event_type": "Positive_regulation", "trigger": {"text": "activated", "start": 2, "end": 2}, "arguments": [{"entity_id": "T6", "text": "pAkt", "role": "Theme"}]}], "entity_mentions": [{"id": "T6", "text": "pAkt", "entity_type": "Protein", "start": 3, "end": 3}, {"id": "T71", "text": "activated", "entity_type": "Positive_regulation", "start": 2, "end": 2}]}
{"doc_id": "PMC-2065877-07-Results-06.txt", "sent_id": "S4", "tokens": ["To", "determine", "if", "Akt", "signaling", "is", "activated", "in", "LMP1", "transgenic", "mice", ",", "pAkt", "and", "several", "of", "its", "targets", "were", "assessed", "by", "immunoblotting", "of", "splenic", "CD19", "+", "MACS-purified", "B", "cells", "."], "sentence": "To determine if Akt signaling is activated in LMP1 transgenic mice , pAkt and several of its targets were assessed by immunoblotting of splenic CD19 + MACS-purified B cells .", "event_mentions": [], "entity_mentions": [{"id": "T7", "text": "Akt", "entity_type": "Protein", "start": 3, "end": 3}, {"id": "T8", "text": "LMP1", "entity_type": "Protein", "start": 8, "end": 8}, {"id": "T9", "text": "pAkt", "entity_type": "Protein", "start": 12, "end": 12}, {"id": "T10", "text": "CD19", "entity_type": "Protein", "start": 24, "end": 24}]}
{"doc_id": "PMC-2065877-07-Results-06.txt", "sent_id": "S5", "tokens": ["LMP1", "transgenic", "B", "cells", "had", "increased", "levels", "of", "pAkt", "compared", "to", "wild-type", "lymphocytes", ";", "however", ",", "progression", "to", "lymphoma", "in", "both", "LMP1", "-", "positive", "and", "-", "negative", "lymphoma", "cells", "did", "not", "further", "increase", "pAkt", "levels", "."], "sentence": "LMP1 transgenic B cells had increased levels of pAkt compared to wild-type lymphocytes ; however , progression to lymphoma in both LMP1 - positive and - negative lymphoma cells did not further increase pAkt levels .", "event_mentions": [{"id": "E4", "event_type": "Positive_regulation", "trigger": {"text": "increased", "start": 5, "end": 5}, "arguments": [{"entity_id": "T12", "text": "pAkt", "role": "Theme"}]}, {"id": "E5", "event_type": "Positive_regulation", "trigger": {"text": "increase", "start": 32, "end": 32}, "arguments": [{"entity_id": "T14", "text": "pAkt", "role": "Theme"}]}], "entity_mentions": [{"id": "T11", "text": "LMP1", "entity_type": "Protein", "start": 0, "end": 0}, {"id": "T12", "text": "pAkt", "entity_type": "Protein", "start": 8, "end": 8}, {"id": "T13", "text": "LMP1", "entity_type": "Protein", "start": 21, "end": 21}, {"id": "T14", "text": "pAkt", "entity_type": "Protein", "start": 33, "end": 33}, {"id": "T72", "text": "increased", "entity_type": "Positive_regulation", "start": 5, "end": 5}, {"id": "T73", "text": "increase", "entity_type": "Positive_regulation", "start": 32, "end": 32}]}
{"doc_id": "PMC-2065877-07-Results-06.txt", "sent_id": "S6", "tokens": ["The", "Akt", "target", "glycogen", "synthase", "kinase", "3", "(", "GSK3", ")", "is", "inactivated", "by", "phosphorylation", ";", "however", ",", "increased", "phosphorylated", "GSK3", "was", "not", "detected", "in", "the", "transgenic", "lymphocytes", "and", "was", "almost", "absent", "in", "the", "lymphoma", "samples", "(", "Figure", "6A", ")", "."], "sentence": "The Akt target glycogen synthase kinase 3 ( GSK3 ) is inactivated by phosphorylation ; however , increased phosphorylated GSK3 was not detected in the transgenic lymphocytes and was almost absent in the lymphoma samples ( Figure 6A ) .", "event_mentions": [{"id": "E6", "event_type": "Binding", "trigger": {"text": "target", "start": 2, "end": 2}, "arguments": [{"entity_id": "T15", "text": "Akt", "role": "Theme"}, {"entity_id": "T16", "text": "glycogen synthase kinase 3", "role": "Theme"}]}, {"id": "E7", "event_type": "Negative_regulation", "trigger": {"text": "inactivated", "start": 11, "end": 11}, "arguments": [{"entity_id": "T74", "text": "target", "role": "Theme"}]}, {"id": "E8", "event_type": "Positive_regulation", "trigger": {"text": "increased", "start": 17, "end": 17}, "arguments": [{"entity_id": "T77", "text": "phosphorylated", "role": "Theme"}]}, {"id": "E9", "event_type": "Phosphorylation", "trigger": {"text": "phosphorylated", "start": 18, "end": 18}, "arguments": [{"entity_id": "T18", "text": "GSK3", "role": "Theme"}]}], "entity_mentions": [{"id": "T15", "text": "Akt", "entity_type": "Protein", "start": 1, "end": 1}, {"id": "T16", "text": "glycogen synthase kinase 3", "entity_type": "Protein", "start": 3, "end": 6}, {"id": "T17", "text": "GSK3", "entity_type": "Protein", "start": 8, "end": 8}, {"id": "T18", "text": "GSK3", "entity_type": "Protein", "start": 19, "end": 19}, {"id": "T74", "text": "target", "entity_type": "Binding", "start": 2, "end": 2}, {"id": "T75", "text": "inactivated", "entity_type": "Negative_regulation", "start": 11, "end": 11}, {"id": "T76", "text": "increased", "entity_type": "Positive_regulation", "start": 17, "end": 17}, {"id": "T77", "text": "phosphorylated", "entity_type": "Phosphorylation", "start": 18, "end": 18}]}
{"doc_id": "PMC-2065877-07-Results-06.txt", "sent_id": "S7", "tokens": ["This", "finding", "indicates", "that", "GSK3", "is", "not", "a", "target", "of", "activated", "Akt", "in", "the", "LMP1", "transgenic", "lymphocytes", "and", "lymphoma", "cells", "."], "sentence": "This finding indicates that GSK3 is not a target of activated Akt in the LMP1 transgenic lymphocytes and lymphoma cells .", "event_mentions": [{"id": "E10", "event_type": "Binding", "trigger": {"text": "target", "start": 8, "end": 8}, "arguments": [{"entity_id": "T19", "text": "GSK3", "role": "Theme"}, {"entity_id": "T20", "text": "Akt", "role": "Theme"}]}, {"id": "E11", "event_type": "Positive_regulation", "trigger": {"text": "activated", "start": 10, "end": 10}, "arguments": [{"entity_id": "T20", "text": "Akt", "role": "Theme"}]}], "entity_mentions": [{"id": "T19", "text": "GSK3", "entity_type": "Protein", "start": 4, "end": 4}, {"id": "T20", "text": "Akt", "entity_type": "Protein", "start": 11, "end": 11}, {"id": "T21", "text": "LMP1", "entity_type": "Protein", "start": 14, "end": 14}, {"id": "T78", "text": "target", "entity_type": "Binding", "start": 8, "end": 8}, {"id": "T79", "text": "activated", "entity_type": "Positive_regulation", "start": 10, "end": 10}]}
{"doc_id": "PMC-2065877-07-Results-06.txt", "sent_id": "S8", "tokens": ["Similarly", ",", "activation", "of", "Akt", "without", "phosphorylation", "of", "GSK3", "has", "been", "previously", "shown", "in", "EBV", "-", "positive", "HD", "[", "40", "]", "."], "sentence": "Similarly , activation of Akt without phosphorylation of GSK3 has been previously shown in EBV - positive HD [ 40 ] .", "event_mentions": [{"id": "E12", "event_type": "Positive_regulation", "trigger": {"text": "activation", "start": 2, "end": 2}, "arguments": [{"entity_id": "T22", "text": "Akt", "role": "Theme"}]}, {"id": "E13", "event_type": "Phosphorylation", "trigger": {"text": "phosphorylation", "start": 6, "end": 6}, "arguments": [{"entity_id": "T23", "text": "GSK3", "role": "Theme"}]}], "entity_mentions": [{"id": "T22", "text": "Akt", "entity_type": "Protein", "start": 4, "end": 4}, {"id": "T23", "text": "GSK3", "entity_type": "Protein", "start": 8, "end": 8}, {"id": "T80", "text": "activation", "entity_type": "Positive_regulation", "start": 2, "end": 2}, {"id": "T81", "text": "phosphorylation", "entity_type": "Phosphorylation", "start": 6, "end": 6}]}
{"doc_id": "PMC-2065877-07-Results-06.txt", "sent_id": "S9", "tokens": ["In", "contrast", ",", "the", "wild-type", "lymphocytes", "lacked", "activated", "Akt", "but", "did", "have", "detectable", "phosphorylated", "GSK3", "."], "sentence": "In contrast , the wild-type lymphocytes lacked activated Akt but did have detectable phosphorylated GSK3 .", "event_mentions": [{"id": "E14", "event_type": "Positive_regulation", "trigger": {"text": "activated", "start": 7, "end": 7}, "arguments": [{"entity_id": "T24", "text": "Akt", "role": "Theme"}]}, {"id": "E15", "event_type": "Phosphorylation", "trigger": {"text": "phosphorylated", "start": 13, "end": 13}, "arguments": [{"entity_id": "T25", "text": "GSK3", "role": "Theme"}]}], "entity_mentions": [{"id": "T24", "text": "Akt", "entity_type": "Protein", "start": 8, "end": 8}, {"id": "T25", "text": "GSK3", "entity_type": "Protein", "start": 14, "end": 14}, {"id": "T82", "text": "activated", "entity_type": "Positive_regulation", "start": 7, "end": 7}, {"id": "T83", "text": "phosphorylated", "entity_type": "Phosphorylation", "start": 13, "end": 13}]}
{"doc_id": "PMC-2065877-07-Results-06.txt", "sent_id": "S10", "tokens": ["This", "further", "suggests", "that", "additional", "pathways", "are", "involved", "in", "the", "regulation", "of", "GSK3", "."], "sentence": "This further suggests that additional pathways are involved in the regulation of GSK3 .", "event_mentions": [{"id": "E16", "event_type": "Regulation", "trigger": {"text": "regulation", "start": 10, "end": 10}, "arguments": [{"entity_id": "T26", "text": "GSK3", "role": "Theme"}]}], "entity_mentions": [{"id": "T26", "text": "GSK3", "entity_type": "Protein", "start": 12, "end": 12}, {"id": "T84", "text": "regulation", "entity_type": "Regulation", "start": 10, "end": 10}]}
{"doc_id": "PMC-2065877-07-Results-06.txt", "sent_id": "S11", "tokens": ["To", "identify", "other", "potential", "Akt", "targets", ",", "immunoblot", "analysis", "for", "p-mTOR", "was", "performed", "."], "sentence": "To identify other potential Akt targets , immunoblot analysis for p-mTOR was performed .", "event_mentions": [{"id": "E17", "event_type": "Binding", "trigger": {"text": "targets", "start": 5, "end": 5}, "arguments": [{"entity_id": "T27", "text": "Akt", "role": "Theme"}]}], "entity_mentions": [{"id": "T27", "text": "Akt", "entity_type": "Protein", "start": 4, "end": 4}, {"id": "T28", "text": "p-mTOR", "entity_type": "Protein", "start": 10, "end": 10}, {"id": "T85", "text": "targets", "entity_type": "Binding", "start": 5, "end": 5}]}
{"doc_id": "PMC-2065877-07-Results-06.txt", "sent_id": "S12", "tokens": ["Activated", "p-mTOR", "was", "not", "increased", "in", "LMP1", "transgenic", "lymphocytes", "or", "lymphoma", "cells", ",", "indicating", "that", "this", "pathway", "is", "not", "affected", "by", "LMP1", "-", "induced", "Akt", "activation", "and", "does", "not", "contribute", "to", "lymphoma", "development", "(", "Figure", "6B", ")", "."], "sentence": "Activated p-mTOR was not increased in LMP1 transgenic lymphocytes or lymphoma cells , indicating that this pathway is not affected by LMP1 - induced Akt activation and does not contribute to lymphoma development ( Figure 6B ) .", "event_mentions": [{"id": "E18", "event_type": "Positive_regulation", "trigger": {"text": "Activated", "start": 0, "end": 0}, "arguments": [{"entity_id": "T29", "text": "p-mTOR", "role": "Theme"}]}, {"id": "E19", "event_type": "Positive_regulation", "trigger": {"text": "increased", "start": 4, "end": 4}, "arguments": [{"entity_id": "T86", "text": "Activated", "role": "Theme"}]}, {"id": "E20", "event_type": "Regulation", "trigger": {"text": "affected", "start": 19, "end": 19}, "arguments": [{"entity_id": "T86", "text": "Activated", "role": "Theme"}, {"entity_id": "T89", "text": "induced", "role": "Cause"}]}, {"id": "E21", "event_type": "Positive_regulation", "trigger": {"text": "induced", "start": 23, "end": 23}, "arguments": [{"entity_id": "T90", "text": "activation", "role": "Theme"}, {"entity_id": "T31", "text": "LMP1", "role": "Cause"}]}, {"id": "E22", "event_type": "Positive_regulation", "trigger": {"text": "activation", "start": 25, "end": 25}, "arguments": [{"entity_id": "T32", "text": "Akt", "role": "Theme"}]}], "entity_mentions": [{"id": "T29", "text": "p-mTOR", "entity_type": "Protein", "start": 1, "end": 1}, {"id": "T30", "text": "LMP1", "entity_type": "Protein", "start": 6, "end": 6}, {"id": "T31", "text": "LMP1", "entity_type": "Protein", "start": 21, "end": 21}, {"id": "T32", "text": "Akt", "entity_type": "Protein", "start": 24, "end": 24}, {"id": "T86", "text": "Activated", "entity_type": "Positive_regulation", "start": 0, "end": 0}, {"id": "T87", "text": "increased", "entity_type": "Positive_regulation", "start": 4, "end": 4}, {"id": "T88", "text": "affected", "entity_type": "Regulation", "start": 19, "end": 19}, {"id": "T89", "text": "induced", "entity_type": "Positive_regulation", "start": 23, "end": 23}, {"id": "T90", "text": "activation", "entity_type": "Positive_regulation", "start": 25, "end": 25}]}
{"doc_id": "PMC-2065877-07-Results-06.txt", "sent_id": "S13", "tokens": ["Akt", "is", "also", "known", "to", "phosphorylate", "and", "induce", "the", "degradation", "of", "the", "pro-apoptotic", "Forkhead", "family", "of", "transcription", "factors", ",", "leading", "to", "cell", "cycle", "progression", "and", "survival", "in", "some", "human", "tumors", "[", "41", ",", "42", "]", "."], "sentence": "Akt is also known to phosphorylate and induce the degradation of the pro-apoptotic Forkhead family of transcription factors , leading to cell cycle progression and survival in some human tumors [ 41 , 42 ] .", "event_mentions": [], "entity_mentions": [{"id": "T33", "text": "Akt", "entity_type": "Protein", "start": 0, "end": 0}]}
{"doc_id": "PMC-2065877-07-Results-06.txt", "sent_id": "S14", "tokens": ["Immunoblot", "analysis", "of", "splenic", "B", "cells", "did", "not", "consistently", "detect", "p", "-", "FoxO1", "levels", ",", "a", "signal", "that", "targets", "FoxO1", "for", "degradation", "."], "sentence": "Immunoblot analysis of splenic B cells did not consistently detect p - FoxO1 levels , a signal that targets FoxO1 for degradation .", "event_mentions": [{"id": "E23", "event_type": "Regulation", "trigger": {"text": "targets", "start": 18, "end": 18}, "arguments": [{"entity_id": "T35", "text": "FoxO1", "role": "Theme"}]}], "entity_mentions": [{"id": "T34", "text": "FoxO1", "entity_type": "Protein", "start": 12, "end": 12}, {"id": "T35", "text": "FoxO1", "entity_type": "Protein", "start": 19, "end": 19}, {"id": "T91", "text": "targets", "entity_type": "Regulation", "start": 18, "end": 18}]}
{"doc_id": "PMC-2065877-07-Results-06.txt", "sent_id": "S15", "tokens": ["Hence", ",", "degradation", "of", "FoxO1", "was", "assessed", "by", "detection", "of", "total", "FoxO1", "levels", "."], "sentence": "Hence , degradation of FoxO1 was assessed by detection of total FoxO1 levels .", "event_mentions": [], "entity_mentions": [{"id": "T36", "text": "FoxO1", "entity_type": "Protein", "start": 4, "end": 4}, {"id": "T37", "text": "FoxO1", "entity_type": "Protein", "start": 11, "end": 11}]}
{"doc_id": "PMC-2065877-07-Results-06.txt", "sent_id": "S16", "tokens": ["Immunoblot", "analysis", "indicated", "that", "total", "FoxO1", "levels", "were", "greatly", "decreased", "in", "wild-type", "and", "LMP1", "transgenic", "lymphomas", "(", "Figure", "6B", ")", ",", "suggesting", "that", "inhibition", "of", "the", "Forkhead", "signaling", "pathway", "is", "an", "important", "target", "of", "Akt", "in", "lymphoma", "development", "."], "sentence": "Immunoblot analysis indicated that total FoxO1 levels were greatly decreased in wild-type and LMP1 transgenic lymphomas ( Figure 6B ) , suggesting that inhibition of the Forkhead signaling pathway is an important target of Akt in lymphoma development .", "event_mentions": [{"id": "E24", "event_type": "Negative_regulation", "trigger": {"text": "decreased", "start": 9, "end": 9}, "arguments": [{"entity_id": "T38", "text": "FoxO1", "role": "Theme"}]}], "entity_mentions": [{"id": "T38", "text": "FoxO1", "entity_type": "Protein", "start": 5, "end": 5}, {"id": "T39", "text": "LMP1", "entity_type": "Protein", "start": 13, "end": 13}, {"id": "T40", "text": "Akt", "entity_type": "Protein", "start": 34, "end": 34}, {"id": "T92", "text": "decreased", "entity_type": "Negative_regulation", "start": 9, "end": 9}]}
{"doc_id": "PMC-2065877-07-Results-06.txt", "sent_id": "S17", "tokens": ["However", ",", "considering", "that", "Akt", "activation", "did", "not", "induce", "FoxO1", "degradation", "in", "LMP1", "transgenic", "B", "cells", ",", "Akt", "may", "not", "be", "the", "sole", "regulator", "of", "FoxO1", ",", "and", "it", "may", "be", "that", "progression", "to", "lymphoma", "requires", "modulation", "of", "multiple", "pathways", "."], "sentence": "However , considering that Akt activation did not induce FoxO1 degradation in LMP1 transgenic B cells , Akt may not be the sole regulator of FoxO1 , and it may be that progression to lymphoma requires modulation of multiple pathways .", "event_mentions": [{"id": "E25", "event_type": "Positive_regulation", "trigger": {"text": "activation", "start": 5, "end": 5}, "arguments": [{"entity_id": "T41", "text": "Akt", "role": "Theme"}]}, {"id": "E26", "event_type": "Positive_regulation", "trigger": {"text": "induce", "start": 8, "end": 8}, "arguments": [{"entity_id": "T95", "text": "degradation", "role": "Theme"}, {"entity_id": "T93", "text": "activation", "role": "Cause"}]}, {"id": "E27", "event_type": "Negative_regulation", "trigger": {"text": "degradation", "start": 10, "end": 10}, "arguments": [{"entity_id": "T42", "text": "FoxO1", "role": "Theme"}]}, {"id": "E28", "event_type": "Regulation", "trigger": {"text": "regulator", "start": 23, "end": 23}, "arguments": [{"entity_id": "T45", "text": "FoxO1", "role": "Theme"}, {"entity_id": "T44", "text": "Akt", "role": "Cause"}]}], "entity_mentions": [{"id": "T41", "text": "Akt", "entity_type": "Protein", "start": 4, "end": 4}, {"id": "T42", "text": "FoxO1", "entity_type": "Protein", "start": 9, "end": 9}, {"id": "T43", "text": "LMP1", "entity_type": "Protein", "start": 12, "end": 12}, {"id": "T44", "text": "Akt", "entity_type": "Protein", "start": 17, "end": 17}, {"id": "T45", "text": "FoxO1", "entity_type": "Protein", "start": 25, "end": 25}, {"id": "T93", "text": "activation", "entity_type": "Positive_regulation", "start": 5, "end": 5}, {"id": "T94", "text": "induce", "entity_type": "Positive_regulation", "start": 8, "end": 8}, {"id": "T95", "text": "degradation", "entity_type": "Negative_regulation", "start": 10, "end": 10}, {"id": "T96", "text": "regulator", "entity_type": "Regulation", "start": 23, "end": 23}]}
{"doc_id": "PMC-2065877-07-Results-06.txt", "sent_id": "S18", "tokens": ["The", "Forkhead", "family", "of", "transcription", "factors", "is", "known", "to", "induce", "the", "expression", "of", "the", "Cdk", "inhibitor", "p27", "[", "43", ",", "44", "]", "."], "sentence": "The Forkhead family of transcription factors is known to induce the expression of the Cdk inhibitor p27 [ 43 , 44 ] .", "event_mentions": [{"id": "E29", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 11, "end": 11}, "arguments": [{"entity_id": "T46", "text": "p27", "role": "Theme"}]}], "entity_mentions": [{"id": "T46", "text": "p27", "entity_type": "Protein", "start": 16, "end": 16}, {"id": "T97", "text": "expression", "entity_type": "Gene_expression", "start": 11, "end": 11}]}
{"doc_id": "PMC-2065877-07-Results-06.txt", "sent_id": "S19", "tokens": ["LMP1", "-", "transformed", "rodent", "fibroblasts", "have", "decreased", "expression", "of", "p27", ",", "upregulation", "of", "Cdk2", ",", "and", "subsequent", "phosphorylation", "and", "inactivation", "of", "the", "tumor", "suppressor", "gene", "Rb", "[", "45", "]", "."], "sentence": "LMP1 - transformed rodent fibroblasts have decreased expression of p27 , upregulation of Cdk2 , and subsequent phosphorylation and inactivation of the tumor suppressor gene Rb [ 45 ] .", "event_mentions": [], "entity_mentions": [{"id": "T47", "text": "LMP1", "entity_type": "Protein", "start": 0, "end": 0}, {"id": "T48", "text": "p27", "entity_type": "Protein", "start": 9, "end": 9}, {"id": "T49", "text": "Cdk2", "entity_type": "Protein", "start": 13, "end": 13}, {"id": "T50", "text": "Rb", "entity_type": "Protein", "start": 25, "end": 25}]}
{"doc_id": "PMC-2065877-07-Results-06.txt", "sent_id": "S20", "tokens": ["To", "investigate", "whether", "LMP1", "affected", "cell", "cycle", "regulation", "through", "the", "Rb", "pathway", "in", "B", "cells", ",", "immunoblot", "analyses", "for", "pRb", ",", "Cdk2", ",", "and", "p27", "were", "performed", "on", "splenic", "CD19", "+", "MACS-purified", "B", "cells", "."], "sentence": "To investigate whether LMP1 affected cell cycle regulation through the Rb pathway in B cells , immunoblot analyses for pRb , Cdk2 , and p27 were performed on splenic CD19 + MACS-purified B cells .", "event_mentions": [], "entity_mentions": [{"id": "T51", "text": "LMP1", "entity_type": "Protein", "start": 3, "end": 3}, {"id": "T52", "text": "Rb", "entity_type": "Protein", "start": 10, "end": 10}, {"id": "T53", "text": "pRb", "entity_type": "Protein", "start": 19, "end": 19}, {"id": "T54", "text": "Cdk2", "entity_type": "Protein", "start": 21, "end": 21}, {"id": "T55", "text": "p27", "entity_type": "Protein", "start": 24, "end": 24}, {"id": "T56", "text": "CD19", "entity_type": "Protein", "start": 29, "end": 29}]}
{"doc_id": "PMC-2065877-07-Results-06.txt", "sent_id": "S21", "tokens": ["LMP1", "transgenic", "B", "cells", "had", "enhanced", "levels", "of", "pRb", "with", "concomitant", "stabilization", "of", "total", "Rb", "levels", "and", "Cdk2", "compared", "to", "wild-type", "B", "lymphocytes", "(", "Figure", "6C", ")", "."], "sentence": "LMP1 transgenic B cells had enhanced levels of pRb with concomitant stabilization of total Rb levels and Cdk2 compared to wild-type B lymphocytes ( Figure 6C ) .", "event_mentions": [{"id": "E30", "event_type": "Positive_regulation", "trigger": {"text": "enhanced", "start": 5, "end": 5}, "arguments": [{"entity_id": "T58", "text": "pRb", "role": "Theme"}]}, {"id": "E31", "event_type": "Positive_regulation", "trigger": {"text": "enhanced", "start": 5, "end": 5}, "arguments": [{"entity_id": "T60", "text": "Cdk2", "role": "Theme"}]}], "entity_mentions": [{"id": "T57", "text": "LMP1", "entity_type": "Protein", "start": 0, "end": 0}, {"id": "T58", "text": "pRb", "entity_type": "Protein", "start": 8, "end": 8}, {"id": "T59", "text": "Rb", "entity_type": "Protein", "start": 14, "end": 14}, {"id": "T60", "text": "Cdk2", "entity_type": "Protein", "start": 17, "end": 17}, {"id": "T98", "text": "enhanced", "entity_type": "Positive_regulation", "start": 5, "end": 5}]}
{"doc_id": "PMC-2065877-07-Results-06.txt", "sent_id": "S22", "tokens": ["Progression", "to", "lymphoma", "in", "both", "wild-type", "and", "LMP1", "transgenic", "lymphoma", "cells", "led", "to", "increased", "levels", "of", "Rb", ",", "correspondingly", "high", "levels", "of", "Cdk2", ",", "and", "decreased", "levels", "of", "p27", "(", "Figure", "6C", ")", "."], "sentence": "Progression to lymphoma in both wild-type and LMP1 transgenic lymphoma cells led to increased levels of Rb , correspondingly high levels of Cdk2 , and decreased levels of p27 ( Figure 6C ) .", "event_mentions": [{"id": "E32", "event_type": "Positive_regulation", "trigger": {"text": "led", "start": 11, "end": 11}, "arguments": [{"entity_id": "T100", "text": "increased", "role": "Theme"}]}, {"id": "E33", "event_type": "Positive_regulation", "trigger": {"text": "increased", "start": 13, "end": 13}, "arguments": [{"entity_id": "T62", "text": "Rb", "role": "Theme"}]}, {"id": "E34", "event_type": "Positive_regulation", "trigger": {"text": "high levels", "start": 19, "end": 20}, "arguments": [{"entity_id": "T63", "text": "Cdk2", "role": "Theme"}]}, {"id": "E35", "event_type": "Negative_regulation", "trigger": {"text": "decreased", "start": 25, "end": 25}, "arguments": [{"entity_id": "T64", "text": "p27", "role": "Theme"}]}], "entity_mentions": [{"id": "T61", "text": "LMP1", "entity_type": "Protein", "start": 7, "end": 7}, {"id": "T62", "text": "Rb", "entity_type": "Protein", "start": 16, "end": 16}, {"id": "T63", "text": "Cdk2", "entity_type": "Protein", "start": 22, "end": 22}, {"id": "T64", "text": "p27", "entity_type": "Protein", "start": 28, "end": 28}, {"id": "T99", "text": "led", "entity_type": "Positive_regulation", "start": 11, "end": 11}, {"id": "T100", "text": "increased", "entity_type": "Positive_regulation", "start": 13, "end": 13}, {"id": "T101", "text": "high levels", "entity_type": "Positive_regulation", "start": 19, "end": 20}, {"id": "T102", "text": "decreased", "entity_type": "Negative_regulation", "start": 25, "end": 25}]}
{"doc_id": "PMC-2065877-07-Results-06.txt", "sent_id": "S23", "tokens": ["These", "data", "indicate", "that", "the", "Rb", "pathway", "is", "deregulated", "in", "LMP1", "transgenic", "lymphocytes", "and", "that", "lymphoma", "cells", "are", "distinguished", "by", "loss", "of", "FoxO1", "and", "decreased", "p27", "."], "sentence": "These data indicate that the Rb pathway is deregulated in LMP1 transgenic lymphocytes and that lymphoma cells are distinguished by loss of FoxO1 and decreased p27 .", "event_mentions": [{"id": "E36", "event_type": "Negative_regulation", "trigger": {"text": "loss", "start": 20, "end": 20}, "arguments": [{"entity_id": "T67", "text": "FoxO1", "role": "Theme"}]}, {"id": "E37", "event_type": "Negative_regulation", "trigger": {"text": "decreased", "start": 24, "end": 24}, "arguments": [{"entity_id": "T68", "text": "p27", "role": "Theme"}]}], "entity_mentions": [{"id": "T65", "text": "Rb", "entity_type": "Protein", "start": 5, "end": 5}, {"id": "T66", "text": "LMP1", "entity_type": "Protein", "start": 10, "end": 10}, {"id": "T67", "text": "FoxO1", "entity_type": "Protein", "start": 22, "end": 22}, {"id": "T68", "text": "p27", "entity_type": "Protein", "start": 25, "end": 25}, {"id": "T103", "text": "loss", "entity_type": "Negative_regulation", "start": 20, "end": 20}, {"id": "T104", "text": "decreased", "entity_type": "Negative_regulation", "start": 24, "end": 24}]}
